Comments
Loading...
Adaptive Biotechnologies Stock Guidance | NASDAQ:ADPT | Benzinga
Adaptive Biotechnologies issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/07/2024 | ADPT | Adaptive Biotechnologies | FY | 2024 | — | — | — | $143.00M | $145.00M | $172.19M | Get Alert |
| 08/01/2024 | ADPT | Adaptive Biotechnologies | FY | 2024 | — | — | — | $140.00M | $145.00M | $167.87M | Get Alert |
| 04/02/2024 | ADPT | Adaptive Biotechnologies | Q1 | 2024 | — | — | — | $41.00M | $43.00M | $38.21M | Get Alert |
| 08/02/2023 | ADPT | Adaptive Biotechnologies | FY | 2023 | — | — | — | $205.00M | $215.00M | $207.17M | Get Alert |
| 05/03/2023 | ADPT | Adaptive Biotechnologies | FY | 2023 | — | — | — | $205.00M | $215.00M | $208.52M | Get Alert |
| 02/14/2023 | ADPT | Adaptive Biotechnologies | FY | 2023 | — | — | — | $205.00M | $215.00M | $218.31M | Get Alert |
| 11/03/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $190.00M | $187.45M | Get Alert |
| 08/03/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $195.00M | $187.62M | Get Alert |
| 05/04/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $195.00M | $189.38M | Get Alert |
| 02/15/2022 | ADPT | Adaptive Biotechnologies | FY | 2022 | — | — | — | $185.00M | $195.00M | $191.87M | Get Alert |
| 01/10/2022 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $153.00M | $154.00M | $153.10M | Get Alert |
| 11/03/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $148.00M | $155.00M | $152.70M | Get Alert |
| 08/04/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $148.00M | $155.00M | $150.16M | Get Alert |
| 05/05/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $145.00M | $155.00M | $149.93M | Get Alert |
| 02/24/2021 | ADPT | Adaptive Biotechnologies | FY | 2021 | — | — | — | $145.00M | $155.00M | $159.15M | Get Alert |
FAQ
What is the most recent guidance for Adaptive Biotechnologies (ADPT)?
There have been no specific sales or earnings guidance reported for Adaptive Biotechnologies in recent months.
Browse guidance and forecast on all stocks.
